Molecularly Targeted Radiation Therapy Using mTOR Inhibition for the Management of Malignant Perivascular Epithelioid Cell Tumor (PEComa): A Case Report and Review

Amishi Bajaj; Mohamed E. Abazeed

doi:10.1016/j.adro.2021.100657

Molecularly Targeted Radiation Therapy Using mTOR Inhibition for the Management of Malignant Perivascular Epithelioid Cell Tumor (PEComa): A Case Report and Review

Amishi Bajaj, Mohamed E. Abazeed^*

^*Corresponding author for this work

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Article number	100657
Journal	Advances in Radiation Oncology
Volume	6
Issue number	3
DOIs	https://doi.org/10.1016/j.adro.2021.100657
State	Published - May 1 2021

Funding

Sources of support: Dr Abazeed is supported by NIH P30CA060553 and R37CA222294 and the American Lung Association . Disclosures: Dr Abazeed discloses research grant and travel support from Siemens Medical Solutions USA and research grant, travel support, and honorarium from Bayer AG for subject matter unrelated to this work.

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.adro.2021.100657

Cite this

@article{46b0153179544d988e444e51021b7a02,

title = "Molecularly Targeted Radiation Therapy Using mTOR Inhibition for the Management of Malignant Perivascular Epithelioid Cell Tumor (PEComa): A Case Report and Review",

author = "Amishi Bajaj and Abazeed, {Mohamed E.}",

note = "Funding Information: Sources of support: Dr Abazeed is supported by NIH P30CA060553 and R37CA222294 and the American Lung Association . Funding Information: Disclosures: Dr Abazeed discloses research grant and travel support from Siemens Medical Solutions USA and research grant, travel support, and honorarium from Bayer AG for subject matter unrelated to this work. ",

year = "2021",

month = may,

day = "1",

doi = "10.1016/j.adro.2021.100657",

language = "English (US)",

volume = "6",

journal = "Advances in Radiation Oncology",

issn = "2452-1094",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Molecularly Targeted Radiation Therapy Using mTOR Inhibition for the Management of Malignant Perivascular Epithelioid Cell Tumor (PEComa)

T2 - A Case Report and Review

AU - Bajaj, Amishi

AU - Abazeed, Mohamed E.

N1 - Funding Information: Sources of support: Dr Abazeed is supported by NIH P30CA060553 and R37CA222294 and the American Lung Association . Funding Information: Disclosures: Dr Abazeed discloses research grant and travel support from Siemens Medical Solutions USA and research grant, travel support, and honorarium from Bayer AG for subject matter unrelated to this work.

PY - 2021/5/1

Y1 - 2021/5/1

UR - http://www.scopus.com/inward/record.url?scp=85108083587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108083587&partnerID=8YFLogxK

U2 - 10.1016/j.adro.2021.100657

DO - 10.1016/j.adro.2021.100657

M3 - Article

C2 - 34195492

AN - SCOPUS:85108083587

SN - 2452-1094

VL - 6

JO - Advances in Radiation Oncology

JF - Advances in Radiation Oncology

IS - 3

M1 - 100657

ER -

Molecularly Targeted Radiation Therapy Using mTOR Inhibition for the Management of Malignant Perivascular Epithelioid Cell Tumor (PEComa): A Case Report and Review

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this